first two years following surgery for high risk renal cell carcinoma (RCC). The objective of this study is to evaluate the utility of surveillance imaging templates to identify recurrences and to describe site specific predictors of early ( 2 years) recurrence for non-metastatic !pT3a RCC patients following surgery at 4 independent centers.
INTRODUCTION AND OBJECTIVES: Partial nephrectomy has become the gold standard in the treatment of clinical T1a renal masses. While tumor characteristics (i.e., nephrometry score) have been found to correlate with postoperative complication rates in some studies, fewer studies have focused on the impact of patient comorbidities on complications. We therefore sought to develop and validate a risk score to predict the probability of major postoperative complications following partial nephrectomy based on patient comorbidities.
METHODS: The Premier Healthcare Database (PHD) (Premier Inc., Charlotte, NC) was used to identify patients who had undergone elective partial nephrectomies. Through review of available ICD9 codes, we identified patient comorbidities and major surgical complications (Clavien grade 3-5). We used half of the set as the training cohort to develop our risk score and the other half as a validation cohort. Covariates with a p-value <0.20 in the univariate analysis were included as candidate variables in the multivariable logistic regression to identify predictors of major complications.
RESULTS: There were 26,778 partial nephrectomies performed between 2003 and 2015. The overall rate of major complications for the whole cohort was 5.6%. The final risk score consisted of 9 predictors listed in Table 1 , and stratifies patients into low, intermediate, high, and very high risk categories. In the training cohort, the area under the receiver-operator characteristic curve (AUC) was 0.72 (95% CI 0.70-0.75) for major complications, while the AUC for the validation cohort was 0.69 (95% CI 0.67-0.72). The predicted probabilities of major complication varied by risk category: low risk ( 3 points) was 2.6% (95% CI 2.2-3.0), intermediate risk (4-11 points) was 4.6% (95% CI 4.2-5.0%), high risk (12-30 points) was 17.6% (95% CI 15.9-19.3), and very high risk (>30 points) was 40.7% (95% CI 30.0-51.2).
CONCLUSIONS: We developed and validated a risk score to predict the risk of postoperative complications following partial nephrectomy based on patient characteristics and comorbidities. Calculation of a risk score can enhance the informed consent process for patients planning to under partial nephrectomy for the management of a renal mass.
METHODS: A retrospective review of our institutional PN database from July 2005 to October 2018 was performed. Of them, we evaluated patients who underwent SAE after PN. Patients' characteristics and clinical outcomes were analyzed.
RESULTS: A total of 2,076 cases underwent PN were evaluated. SAE was performed in 41 (1.97%) patients who underwent Open PN (19/1171, 1.62%), laparoscopic PN (4/60, 6.67%), Robot assisted PN (18/845, 2.37%), respectively. The median period from PN to SAE was 12 days (interquartile range 8-24). The most common symptom of 31(75.61%) patients presented with gross hematuria. Other symptoms were flank pain (3/41, 7.32%). Asymptomatic 7 patients represented pseudoaneurysm in follow up CT. The main reason for SAE on angiography was pseudoanuerysm (32/41, 78.05%). And there were arteriovenous fistula (5/41, 12.20%), contrast extravasation (4/41, 9.76%). SAE was performed using endovascular coils or n-butyl-2-cyanoacrylate (NBCA). Technical and clinical successes were achieved in all patients (100%). There were no episodes of bleeding recurrence during the follow-up period. The embolization group and the control group showed 89.8% and 92.2% eGFR preservation after PN, respectively. There was no statistical difference between the two groups. (p[0.376) There was no statistically significant difference in surgical methods and baseline characteristics such as age, BMI, eGFR (estimated glomerular filtration rate) between two groups. In the embolization group, feature of renal tumors showed endophytic (28/41, 68.29%) and posterior. (25/41, 60.98%). But R.E.N.A.L score and PADUA score did not differ between the two groups.
CONCLUSIONS: SAE is a successful method of controlling postoperative bleeding while preserving renal function after PN. Urologists should also pay attention to renorrhaphy of PN for renal masses located endophytic and posterior. 
INTRODUCTION AND OBJECTIVES:
Renal cell carcinoma is unique in its propensity for vascular propagation via inferior vena cava (IVC) tumor thrombus. This is typically managed with radical nephrectomy and IVC thrombectomy. Caval resection and/or ligation of the IVC may be indicated in patients with large defects or significant residual bland thrombus burden with adequate collateralization. We examined our institutional experience to describe the effect of IVC ligation on perioperative outcomes and survival.
METHODS: We performed a retrospective chart review of patients who underwent nephrectomy with IVC thrombectomy at a large tertiary referral institution between 1990 and 2018. Baseline demographics, perioperative details, pathology reports, and long-term follow up data were reviewed. The data was analyzed using chisquare and Fisher's exact tests, Kaplan-Meier curves, and Wilcoxon tests.
RESULTS: 360 patients with a median age of 63 underwent nephrectomy with IVC thrombectomy were included in the analysis. 69% of these were men and 71% of tumors were right-sided. 85% of tumors in this cohort were level 2 or higher. Cavectomy was performed in 64(18%) of patients with 56% managed via primary reconstruction and 24% via graft reconstruction. The IVC was ligated in a total of 20 patients (5.5% of cohort 
